InsiderGauge
Checking updates…
Dashboard

Venrock Healthcare Capital Partners III, L.P.insider trades

In SEC Form 4 filings, Venrock Healthcare Capital Partners III, L.P. is listed as 10% owner of Lycia Therapeutics, Inc. (LYCA). In the last 90 days, Venrock Healthcare Capital Partners III, L.P. bought $37.65M of Lycia Therapeutics, Inc. (LYCA) on the open market and sold none. The largest purchase was $35.00M of Lycia Therapeutics, Inc. (LYCA) on Oct 26.

Companies and roles

CompanyRoleTransactionsLast filed
LYCALycia Therapeutics, Inc.10% owner9Oct 27

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-27

CompanyTradedFiledTypeSharesPriceValueOwned after10b5-1 planFiling
LYCALycia Therapeutics, Inc.Oct 27Oct 27P8,729$25.84Purchase +$225,5576,794,166NoForm 4
LYCALycia Therapeutics, Inc.Oct 27Oct 27P31,067$26.84Purchase +$833,8386,825,233NoForm 4
LYCALycia Therapeutics, Inc.Oct 26Oct 27C4,779,793not reportednot reported4,832,732NoForm 4
LYCALycia Therapeutics, Inc.Oct 26Oct 27P1,944,444$18.00Purchase +$34,999,9926,777,176NoForm 4
LYCALycia Therapeutics, Inc.Oct 26Oct 27P8,261$26.97Purchase +$222,7996,785,437NoForm 4
LYCALycia Therapeutics, Inc.Oct 26Oct 27C · derivative17,142,578$0.00$0not reportedNoForm 4
LYCALycia Therapeutics, Inc.Oct 26Oct 27C · derivative4,408,091$0.00$0not reportedNoForm 4
LYCALycia Therapeutics, Inc.Oct 23Oct 27P24,560$25.68Purchase +$630,70124,560NoForm 4
LYCALycia Therapeutics, Inc.Oct 23Oct 27P28,379$26.11Purchase +$740,97652,939NoForm 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.